Xenoport, Inc.

Santa Clara, CA 95051

Market Performance

NASDAQ: XNPT
52 Week High $7.86
52 Week Low $3.35

SBIR Award Summary

Total Number of Awards 3
Total Value of Awards $1.35MM
First Award Date 04/01/02
Most Recent Award Date 03/01/04

Key Personnel

Last Name Name Awards Contact
Dower William J Dower 3

3 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/04 - 02/28/05

DESCRIPTION (provided by applicant): XenoPort will use NIH funding to develop a novel phage display method for identifying useful transcytotic pathways for oral administration of therapeutic drugs, and for identification of therapeutic molecules. Current methods for oral delivery of macromolecular and other drugs poorly absorbed by the intestine...

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 03/01/03 - 02/29/04

DESCRIPTION (provided by applicant): XenoPort will use NIH funding to develop a novel phage display method for identifying useful transcytotic pathways for oral administration of therapeutic drugs, and for identification of therapeutic molecules. Current methods for oral delivery of macromolecular and other drugs poorly absorbed by the intestine...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 04/01/02 - 09/30/02

DESCRIPTION (provided by applicant): Current methods for oral delivery of macromolecular and other drugs poorly absorbed by the intestine do not provide adequate oral bio-availability. Thus, new intestinal pathways to transport larger quantities of compound must be identified. Unfortunately, current methods...